1. Home
  2. BEAM vs AIR Comparison

BEAM vs AIR Comparison

Compare BEAM & AIR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BEAM
  • AIR
  • Stock Information
  • Founded
  • BEAM 2017
  • AIR 1951
  • Country
  • BEAM United States
  • AIR United States
  • Employees
  • BEAM N/A
  • AIR N/A
  • Industry
  • BEAM Biotechnology: Biological Products (No Diagnostic Substances)
  • AIR Aerospace
  • Sector
  • BEAM Health Care
  • AIR Industrials
  • Exchange
  • BEAM Nasdaq
  • AIR Nasdaq
  • Market Cap
  • BEAM 1.9B
  • AIR 2.1B
  • IPO Year
  • BEAM 2020
  • AIR 1988
  • Fundamental
  • Price
  • BEAM $29.01
  • AIR $60.50
  • Analyst Decision
  • BEAM Buy
  • AIR Strong Buy
  • Analyst Count
  • BEAM 10
  • AIR 5
  • Target Price
  • BEAM $47.67
  • AIR $81.00
  • AVG Volume (30 Days)
  • BEAM 1.2M
  • AIR 239.7K
  • Earning Date
  • BEAM 11-05-2024
  • AIR 01-07-2025
  • Dividend Yield
  • BEAM N/A
  • AIR N/A
  • EPS Growth
  • BEAM N/A
  • AIR N/A
  • EPS
  • BEAM N/A
  • AIR 1.81
  • Revenue
  • BEAM $349,643,000.00
  • AIR $2,430,900,000.00
  • Revenue This Year
  • BEAM N/A
  • AIR $17.43
  • Revenue Next Year
  • BEAM $10.82
  • AIR $7.27
  • P/E Ratio
  • BEAM N/A
  • AIR $33.53
  • Revenue Growth
  • BEAM 328.73
  • AIR 16.09
  • 52 Week Low
  • BEAM $20.84
  • AIR $54.71
  • 52 Week High
  • BEAM $49.50
  • AIR $76.34
  • Technical
  • Relative Strength Index (RSI)
  • BEAM 56.94
  • AIR 33.90
  • Support Level
  • BEAM $24.96
  • AIR $62.70
  • Resistance Level
  • BEAM $29.53
  • AIR $64.36
  • Average True Range (ATR)
  • BEAM 2.05
  • AIR 1.89
  • MACD
  • BEAM -0.04
  • AIR -0.98
  • Stochastic Oscillator
  • BEAM 67.05
  • AIR 4.78

About BEAM Beam Therapeutics Inc.

Beam Therapeutics Inc is a biotechnology company engaged in creating genetic medicines based on its base editing technology. This technology enables a new class of genetic medicines that targets a single base in the genome without making a double-stranded break in the DNA. The company's portfolio comprises Gene Correction, Gene Modification, Gene Activation, Gene Silencing, and Multiplex Editing. The company's pipeline programs consist of BEAM-101, ESCAPE, BEAM-302, BEAM-301, and BEAM-201.

About AIR AAR Corp.

AAR Corp is engaged in providing products and services to aviation, government, and defense market. It operates in two segments namely Aviation Services and Expeditionary Services. The Aviation Services segment consists of aftermarket support and services businesses that provide spares and maintenance support for aircraft operated by it's commercial and government/defense customers. The Expeditionary Services segment consists of businesses that provide products and services supporting the movement of equipment and personnel by the U.S. Department of Defense, foreign governments, and non-governmental organizations. It generates a majority of its revenue from the Aviation Services Segment.

Share on Social Networks: